Publications by authors named "Dennis Demont"

Claim this Profile
D
Discovery and optimization of covalent EGFR T790M/L858R mutant inhibitors.
Niels Hoogenboom, Dennis Demont, Edwin de Zwart, Saskia Verkaik, Maaike Emmelot

Bioorg Med Chem Lett· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of quinoline-based irreversible BTK inhibitors.
Gerjan de Bruin, Dennis Demont, Edwin de Zwart, Saskia Verkaik, Niels Hoogenboom

Bioorg Med Chem Lett· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acalabrutinib (ACP-196): A Covalent Bruton Tyrosine Kinase Inhibitor with a Differentiated Selectivity and In Vivo Potency Profile.
Tjeerd Barf, Todd Covey, Raquel Izumi, Bas van de Kar, Michael Gulrajani, Dennis Demont

J Pharmacol Exp Ther· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based lead identification of ATP-competitive MK2 inhibitors.
Tjeerd Barf, Allard Kaptein, Sander de Wilde, Ruud van der Heijden, Richard van Someren, Dennis Demont

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.
Nicole C R van Straten, Twan H J van Berkel, Dennis R Demont, Willem-Jan F Karstens, Remco Merkx

J Med Chem· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis